The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: An Italian multicentre longitudinal observational pilot study

Clinical Rheumatology

Volumn 30, Issue 8, 2011, Pages 1063-1067

  Scarpa, Raffaele ^a   Atteno, Mariangela ^a   Lubrano, Ennio ^b   Provenzano, Giuseppe ^c   D'Angelo, Salvatore ^b,d   Spadaro, Antonio ^e   Costa, Luisa ^a   Olivieri, Ignazio ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c 'Ao Villa SOFIA CTO'   (Italy)

^d SAN CARLO HOSPITAL   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

DAS28; Early disease; EULAR response criteria; Psoriatic arthritis; TNF blockers

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEMYELINATING DISEASE; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; ITALY; LONGITUDINAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTPATIENT; PATIENT SATISFACTION; PILOT STUDY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, PSORIATIC; FEMALE; HEALTH STATUS; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PILOT PROJECTS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 80052572110     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1680-y     Document Type: Article

References (20)

1. P Emery 1994 The Roche Rheumatology Prize Lecture. The optimal management of early rheumatoid arthritis: the key to preventing disability Br J Rheumatol 33 765 768 8055205 10.1093/rheumatology/33.8.765 1:STN:280:DyaK2czjt1Cluw%3D%3D (Pubitemid 24249186)
2. DD Gladman 2009 Psoriatic arthritis from Wright's era until today J Rheumatol 36 suppl.83 4 8
3. R Scarpa A Cuocolo R Peluso M Atteno P Gisonni S Iervolino, et al. 2008 Early psoriatic arthritis J Rheumatol 35 137 141 18050372
4. D Buskila P Langevitz DD Gladman S Urowitz 1992 Smythe HA Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis J Rheumatol 19 1115 1119 1512768 1:STN:280:DyaK38zotFOitQ%3D%3D
5. SM Jones JB Armas MG Cohen CR Lovell G Evison NJ McHugh 1994 Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease Br J Rheumatol 33 834 839 8081668 10.1093/rheumatology/33.9.834 1:STN:280:DyaK2czmtlWntg%3D%3D (Pubitemid 24283222)
6. DD Gladman PJ Mease 2006 Towards international guides for the management of psoriatic arthritis J Rheumatol 33 1228 1230 16821263 (Pubitemid 44025130)
7. W Taylor DD Gladman P Helliwell A Marchesoni P Mease H Mielants The CASPAR Study Group 2006 Classification criteria for psoriatic arthritis. Development of new criteria from a large international study Arthritis Rheum 54 2665 2673 16871531 10.1002/art.21972 (Pubitemid 44205029)
8. M Bocchino A Matarese B Bellofiore P Giacomelli G Santoro N Balato, et al. 2008 Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment Eur J Clin Microbiol Infect Dis 27 10 907 913 18470544 10.1007/s10096-008-0519-1 1:CAS:528:DC%2BD1cXht1amsrzN
9. M Rudwaleit A Metter J Listing J Sieper J Braun 2006 Inflammatory back pain in ankylosing spondylitis: a reassement of the clinical history for application as classification and diagnostic criteria Arthritis Rheum 54 569 578 16447233 10.1002/art.21619 (Pubitemid 43228633)
10. K Ikeda S Cox P Emery 2007 Biological therapy in early arthritis-overtreatment or the the way to go? Arthritis Res Ther 9 211 17540047 10.1186/ar2177 (Pubitemid 350148952)
11. P Emery B McInnes R van Vollenhoven MC Kraan 2008 Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis Rheumatology 47 392 398 18094000 10.1093/rheumatology/ kem257 1:CAS:528:DC%2BD1cXmslKhtro%3D
12. R Scarpa R Peluso M Atteno F Manguso A Spanò S Iervolino, et al. 2008 The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate Clin Rheumatol 27 823 826 18030515 10.1007/s10067-007-0787-7
13. JM Gelfand AL Neimann DB Shin X Wnag DJ Margolis AB Troxel 2006 Risk of myocardial infarction in patients with psoriasis JAMA 296 1735 1741 17032986 10.1001/jama.296.14.1735 1:CAS:528:DC%2BD28XhtVyjs77F (Pubitemid 44547793)
14. DD Gladman 2008 Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis Nat Clin Pract Rheumatol 4 510 511 18695713 10.1038/ncprheum0880 1:CAS:528:DC%2BD1cXhtFKku7vM
15. AA Saad DM Ashcroft KD Watson DPM Symmons PR Noyce KL Hyrich on behalf of the BSRBR 2010 Efficacy and safety of anti-TNF therapies in arthritis: an observational study from the British Society for Rheumatology Biologics Register Rheumatology 49 697 705 20056769 10.1093/rheumatology/kep423 1:CAS:528:DC%2BC3cXjslegtLc%3D
16. J Fransen C Antoni PJ Mease, et al. 2006 Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomized, controlled trials of two anti TNF inhibitors Ann Rheum Dis 65 1373 1378 16644783 10.1136/ard.2006.051706 1:CAS:528: DC%2BD28Xht1egsLfO (Pubitemid 44620449)
17. DD Gladman PJ Mease P Healy O Fitzgerald A Cauli E Lubrano, et al. 2007 Outcome measure in psoriatic arthritis J Rheumatol 34 1159 1166 17477479
18. A Spadaro F Ceccarelli R Scrivo G Valesini 2008 Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis Ann Rheum Dis 67 1650 1651 18854519 10.1136/ard.2007.085951 1:CAS:528: DC%2BD1cXhtl2gtr7I
19. KL Hyrich KD Watson AJ Silman DP Symmons 2006 Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register Rheumatology 45 1558 1565 16705046 10.1093/rheumatology/kel149 1:CAS:528:DC%2BD28Xht1Kns73E (Pubitemid 44817065)
20. I Olivieri S de Portu C Salvarani A Cauli E Lubrano A Spadaro, et al. 2008 The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumor necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy Rheumatology 47 1664 1670 18725374 10.1093/rheumatology/ken320 1:STN:280:DC%2BD1cnmvFKgsg%3D%3D